$132.93+17.17% · 3M
Moving avg
1W+3.59%
1M+7.18%
3M+17.17%
6M+11.46%
YTD+24.88%
1Y+65.54%
3Y+22.05%
5Y+74.82%
52-week range
$76.66100% of range$131.74
Company health
Value1/6
Growth2/6
Profitability6/6
Health4/6
Dividend4/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- Strong 28% net margin
- High return on equity (1793%)
- Pays a 2.6% dividend
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$328.31B
Enterprise value
$367.51B
P/E ratio (TTM)
36.82x
P/S ratio (TTM)
4.94x
EV/EBITDA
19.57x
Per share & returns
EPS (TTM)
$3.61
Dividend yield
2.56%
Beta (1Y)
0.20
30-day change
+7.18%
Trading
Volume (24h)
7.77M
Previous close
$130.42
Shares outstanding
2.47B
About Merck & Co., Inc.
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Symbol
MRK
Merck & Co., Inc. is a mega-cap healthcare company in the Drug Manufacturers - General industry. Its shares are listed on NYSE (United States) and trade under the ticker MRK.
Frequently asked questions
What is Merck & Co., Inc.'s market cap?
Merck & Co., Inc. (MRK) has a market capitalization of $328.31B.
What is Merck & Co., Inc.'s P/E ratio?
Merck & Co., Inc. trades at a price-to-earnings (P/E) ratio of 36.82.
What exchange does MRK trade on?
MRK trades on NYSE.
Appears in
Compare & explore
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.92B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.41B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.93B cap
Amgen Inc.AMGN
$416.18+0.45%
$224.62B cap